Jeonghwan Youk

机构：Seoul National University, Korea Advanced Institute of Science and Technology, New Generation University College, Seoul National University Hospital, National University College · ORCID：0000-0002-6761-3958

发表论文 125 篇 · 总被引 2030 次 · h-index 19

代表论文

• Central Nervous System Activity of Lazertinib in EGFR ‐Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG‐LU20‐15 and LU21‐01 (2026 · Thoracic Cancer)
• EZH1/2 inhibition selectively targets SMARCA4/2 co-deficient lung cancer cells by suppressing stemness and proliferation (2026 · Neoplasia)
• In vitro evaluation of sacituzumab govitecan in non-small cell lung cancer with actionable genomic alterations (2026 · Translational Oncology)
• Metastasis-related genomic aberrations and evolutionary trajectory in uveal melanoma (2026 · Experimental & Molecular Medicine)
• SPECTRUM: Phase II study of tislelizumab plus pemetrexed in patients with relapsed or refractory (R/R) primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS)—The Korean Cancer Study Group LY22-07. (2026 · Journal of Clinical Oncology)
• Abstract 2699: Accumulation of somatic mutation and clonal architecture of fallopian tube epithelium. (2026 · Cancer Research)